BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients
To evaluate BRCA1/2 immunohistochemistry (IHC) as a screening test for germline BRCA1/2 in epithelial ovarian cancer (EOC), tumor tissue from 105 EOC patients who had germline BRCA mutations, including 9 BRCA1 mutations, 6 BRCA2 mutations and 90 no BRCA mutations, were studied. Paraffin-embedded tis...
Main Authors: | Tarinee Manchana, Patou Tantbirojn, Natkrita Pohthipornthawat |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-08-01
|
Series: | Gynecologic Oncology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352578920300485 |
Similar Items
-
Somatic BRCA Mutation in High Grade Epithelial Ovarian Cancer Patients
by: Tarinee Manchana, et al.
Published: (2019-01-01) -
BRCA mutation in high grade epithelial ovarian cancers
by: Tarinee Manchana, et al.
Published: (2019-08-01) -
Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcome
by: Ashour M, et al.
Published: (2019-07-01) -
BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: update
by: Alena Savanevich, et al.
Published: (2021-01-01) -
Frequency of BRCA1 and BRCA2 mutations in ovarian cancer patients in South-East Poland
by: Andrzej Jasiewicz, et al.
Published: (2022-04-01)